Heart Beat: Generic ARBs are coming
The FDA has approved the sale of a generic version of the angiotensin-receptor blocker medication losartan, and generic versions of two other ARBs may soon follow.
Content restricted. Requires subscription
The FDA has approved the sale of a generic version of the angiotensin-receptor blocker medication losartan, and generic versions of two other ARBs may soon follow.